| Unique ID issued by UMIN | UMIN000059219 |
|---|---|
| Receipt number | R000067718 |
| Scientific Title | Impact of Fermented Whey Protein Intake on Plasma Amino Acid Kinetics |
| Date of disclosure of the study information | 2025/09/29 |
| Last modified on | 2025/09/29 10:18:34 |
Fermented Whey Protein Study
FWP Study
Impact of Fermented Whey Protein Intake on Plasma Amino Acid Kinetics
WP-AAD Study
| Japan |
Not applicable: Healthy male volunteers
| Adult |
Others
NO
To elucidate the time course changes in plasma amino acid concentrations in humans after acute ingestion of fermented whey protein.
Others
To investigate the effects of post ingestion serum treatment on protein metabolism related responses in cultured skeletal muscle cells (C2C12), including exploratory comparisons between young and older men.
Confirmatory
Explanatory
Not applicable
Time-course changes in plasma amino acid concentrations in humans (pre-ingestion, 45, 60, 75, and 90 minutes post-ingestion).
Responses of C2C12 myotubes to post-ingestion serum treatment, including indices of protein synthesis and expression of signaling molecules.
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Prevention
| Food |
Whey protein (FrieslandCampina). A single oral ingestion of 13.5 g protein dissolved in 200 mL water on one study day (once daily, one day only). The trial is conducted in a crossover design with approximately one week washout between interventions.
Fermented whey protein (Biotis Fermentis, FrieslandCampina). A single oral ingestion of 13.5 g protein dissolved in 200 mL water on one study day (once daily, one day only). The trial is conducted in a crossover design with approximately one week washout between interventions.
| 18 | years-old | < |
| 79 | years-old | >= |
Male
Healthy males aged 18-40 years or 65-79 years
Those judged to have no health problems based on a screening examination conducted by the principal investigator or co-investigators
Individuals who have received a full explanation of the study purpose and procedures, and who have provided written informed consent
Individuals with milk allergy
Individuals with other food allergies
Individuals who habitually perform resistance training
Individuals who habitually consume amino acid or protein supplements
Individuals with hepatitis B or C virus infection, or suspected infection
Individuals with a history of cardiovascular disease, such as heart disease or hypertension
Individuals taking anticoagulant medications (e.g., warfarin)
Any other individuals deemed unsuitable by the principal investigator or study physician
24
| 1st name | Satoshi |
| Middle name | |
| Last name | Fujita |
Ritsumeikan University
Faculty of Sport and Health Science
525-8577
1-1-1, Nojihigashi, Kusatsu, Shiga
077-561-5229
safujita@fc.ritsumei.ac.jp
| 1st name | Satoshi |
| Middle name | |
| Last name | Fujita |
Ritsumeikan University
Faculty of Sport and Health Science
525-8577
1-1-1, Nojihigashi, Kusatsu, Shiga
077-561-5229
safujita@fc.ritsumei.ac.jp
Ritsumeikan University
FrieslandCampina
Outside Japan
Netherlands
Ritsumeikan University
1-1-1 Nojihigashi, Kusatsu, Shiga
077-599-4175
b-rinri@st.ritsumei.ac.jp
NO
立命館大学(滋賀県)
| 2025 | Year | 09 | Month | 29 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 06 | Month | 24 | Day |
| 2025 | Year | 07 | Month | 29 | Day |
| 2025 | Year | 08 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 09 | Month | 29 | Day |
| 2025 | Year | 09 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067718